Rafferty Asset Management
CGON icon

Rafferty Asset Management’s CG Oncology CGON Stock Holding History

Rafferty Asset Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.6M Sell
67,979
-38,073
-36% -$2.16M 0.02% 410
2025
Q4 		$4.4M Buy
106,052
+44,368
+72% +$1.84M 0.02% 461
2025
Q3 		$2.48M Sell
61,684
-18,544
-23% -$539K 0.01% 595
2025
Q2 		$2.09M Buy
80,228
+8,802
+12% +$212K 0.01% 599
2025
Q1 		$1.75M Sell
71,426
-7,295
-9% -$205K 0.01% 610
2024
Q4 		$2.26M Buy
78,721
+126
+0.2% +$4.31K 0.01% 621
2024
Q3 		$2.97M Buy
78,595
+27,630
+54% +$969K 0.01% 540
2024
Q2 		$1.61M Buy
+50,965
New +$1.77M 0.01% 702

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM